Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Healthcare Leaders Merge to Accelerate the Promise of Value-Based Care

Mingle Analytics and SilverVue form Mingle Health to deliver an all-in-one platform that includes the consulting, analytics, and tools to streamline medical practices, integrate the delivery network, and improve patient outcomes.

Medicaid work requirements in Arkansas jeopardize millions in funding

Hundreds of millions of dollars in federal funding may be in jeopardy as a result of Arkansas' Medicaid work requirement program, according to a recent analysis from the Commonwealth Fund.

Thumbnail

CVS earnings outpace expectations as Aetna deal chugs along

On the cusp of completing a $69 billion merger with the nation’s third-largest health insurance provider, Aetna, CVS Health reported strong earnings that beat analysts’ expectations.

Thumbnail

Survey says strong optimism for healthcare M&A in 2019

Healthcare M&A isn’t expected to slow down next year, according to a survey of healthcare executives by Capital One.

Thumbnail

CMS cuts hospital outpatient rates in final rule

CMS plans to cut $380 million in 2019 by establishing site-neutral payments to hospitals. The change, which was outlined in CMS’ Outpatient Prospective Payment System final rule on Friday, will lower out-of-pocket costs for beneficiaries but also reduce payments for hospital-owned outpatient settings.

Thumbnail

CMS finalizes physician fee schedule, delaying controversial coding change

CMS finalized the Physician Fee Schedule and Quality Payment Program, delaying a controversial coding change that would have resulted in a payment cut for doctors.

Thumbnail

CMS finalizes new payment model for home health, boosts reimbursements for 2019

CMS finalized the 2019 home health prospective payment system, cementing a new payment model for the post-acute care space in 2020 and increasing payments for 2019.

Thumbnail

FDA clears 23andMe genetic testing to market on drug metabolism

The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.